NEW AWARD - DEFINING OVEREXPRESSION OF MYBL2 AS A DRIVER OF LETHAL PROSTATE CANCER...SIGNED 4/13/2020, EFFECTIVE 5/1/2020, DISTRIBUTED 4/14/2020, FAADC 4/15/2020
$1,234,189FY2020Defense Health AgencyDOD
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.